“We found that vitamin D supplementation may alleviate ADHD symptoms, which were supported by improvements in ADHD total scores, inattention scores, hyperactivity scores, and behavior scores,” the authors stated.

Adhansia XR (methylphenidate HCl extended-release capsules) is expected to be available as of July 15, 2019 for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older, according to Adlon Therapeutics.

A recent study published in the New England Journal of Medicine assessed the risk of new-onset psychosis among adolescents and young adults with attention deficit hyperactivity disorder (ADHD) initiated on various stimulant medications.